{"answer":{"query":"vraylar","resolved_as":"name","packages":26,"applications":["NDA204370"],"identity":{"application_numbers":["NDA204370"],"marketing_categories":["NDA"],"labelers":[{"text":"ALLERGAN, INC.","untrusted":true}],"dosage_forms":[{"text":"CAPSULE, GELATIN COATED","untrusted":true}],"marketing_start":{"earliest":"2016-03-01","latest":"2025-12-18","packages_with_a_start_date":9}},"price":{"median_negotiated_over_nadac":null,"packages_compared":0,"packages_listed":26,"negotiated_price_ends":null,"rows":[{"ndc":"61874011511","name":{"text":"VRAYLAR CAPSULES 1.5MG (Inner Pack)","untrusted":true},"class":"B","nadac_per_unit":50.83235,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011517","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011520","name":{"text":"VRAYLAR CAPSULES 1.5MG","untrusted":true},"class":"B","nadac_per_unit":50.83235,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011530","name":{"text":"VRAYLAR (Cariprazine) 1.5MG","untrusted":true},"class":"B","nadac_per_unit":50.83235,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011531","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011563","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874011590","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013011","name":{"text":"VRAYLAR CAPSULES 3MG (Inner Pack)","untrusted":true},"class":"B","nadac_per_unit":50.86166,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013020","name":{"text":"VRAYLAR CAPSULES 3MG","untrusted":true},"class":"B","nadac_per_unit":50.86166,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013030","name":{"text":"VRAYLAR (Cariprazine) 3MG","untrusted":true},"class":"B","nadac_per_unit":50.86166,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013031","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013063","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874013090","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874014511","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874014530","name":{"text":"VRAYLAR (Cariprazine) 4.5MG","untrusted":true},"class":"B","nadac_per_unit":50.78253,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874014563","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874014590","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874016011","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874016030","name":{"text":"VRAYLAR (Cariprazine) 6MG","untrusted":true},"class":"B","nadac_per_unit":50.76302,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874016063","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874016090","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874017008","name":{"text":"VRAYLAR (Cariprazine) 1.5MG / 3MG Blister","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874025030","name":{"text":"Vraylar Capsules 0.5 MG 30","untrusted":true},"class":"B","nadac_per_unit":50.76781,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"61874027530","name":{"text":"Vraylar Capsule 0.75 MG 30","untrusted":true},"class":"B","nadac_per_unit":50.8085,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"70518315700","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null}],"negotiated_scheduled":{"thirty_day":770,"effective":"2027-01-01"}},"generic_entry":[{"application":"NDA204370","date":"2030-03-17","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"7737142*PED","productNo":"001"},"latest_patent_expiry":"2030-03-17","latest_exclusivity_expiry":"2029-06-18","dated_barriers":67,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":5,"exclusivities_listed":3,"fact_id":"f1f46a95e84106b29c2cec11"}],"label_history":{"events_total":11,"non_cmc_events":11,"counts_by_class":{"EFFICACY":7,"LABELING":4},"cmc_events":0,"recent_non_cmc_events":[{"application":"NDA204370","submission_no":17,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2025-12-18","documents":[{"type":"Letter","date":"2025-12-19","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204370Orig1s014,s015,s016,s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-22","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204370s014s015s016s017lbl.pdf","untrusted":true}}],"fact_id":"edd08c5b096812a808f08f48"},{"application":"NDA204370","submission_no":16,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2025-12-18","documents":[{"type":"Letter","date":"2025-12-19","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204370Orig1s014,s015,s016,s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-22","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204370s014s015s016s017lbl.pdf","untrusted":true}}],"fact_id":"2b96c5ee7179871443e0eaa1"},{"application":"NDA204370","submission_no":15,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2025-12-18","documents":[{"type":"Letter","date":"2025-12-19","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204370Orig1s014,s015,s016,s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-22","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204370s014s015s016s017lbl.pdf","untrusted":true}}],"fact_id":"744931a8ea68c9e13af34abf"},{"application":"NDA204370","submission_no":14,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2025-12-18","documents":[{"type":"Letter","date":"2025-12-19","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204370Orig1s014,s015,s016,s017ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-12-22","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204370s014s015s016s017lbl.pdf","untrusted":true}}],"fact_id":"2f33dbbbdf8759849cc154b5"},{"application":"NDA204370","submission_no":12,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2024-11-22","documents":[{"type":"Label","date":"2024-11-25","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf","untrusted":true}},{"type":"Letter","date":"2024-11-26","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/204370Orig1s012ltr.pdf","untrusted":true}}],"fact_id":"af5a4bda7dd5af2d64b318fe"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":6,"te_code_counts":{"AB":4,"NOT_PROVIDED":2},"marketing_status_counts":{"Prescription":6},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA204370","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 3MG BASE","untrusted":true}},{"application":"NDA204370","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 1.5MG BASE","untrusted":true}},{"application":"NDA204370","product_no":"004","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 6MG BASE","untrusted":true}},{"application":"NDA204370","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 4.5MG BASE","untrusted":true}},{"application":"NDA204370","product_no":"006","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 0.75MG BASE","untrusted":true}},{"application":"NDA204370","product_no":"005","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"VRAYLAR","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 0.5MG BASE","untrusted":true}}]},"supply":{"fda_shortage_status_counts":{},"packages_with_a_termination_date":1,"next_package_termination_dates":[],"packages_with_future_termination_date":0,"termination_meaning":"manufacturer-reported last-lot expiry or withdrawal date of one package; other packages and generics can remain"},"trials":{"attribution":"Source: ClinicalTrials.gov","modification_statement":"OmniRx has summarized and trimmed this ClinicalTrials.gov data.","not_an_offer":"A recruiting trial listing is not an offer of free drug and not medical advice; enrollment is decided by the study team.","ingredients":[{"ingredient":{"text":"CARIPRAZINE","untrusted":true},"recruiting_interventional_count":6,"not_yet_recruiting_count":5,"by_phase":{"PHASE4":2,"PHASE1":1,"PHASE3":2,"PHASE1/PHASE2":1},"registry_processing_date":"2026-11-06T10:00:05","modifications":"Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited.","recent_trials":[{"nct_id":"NCT05913947","title":{"text":"Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Aalborg University Hospital","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-29","start_date":"2022-12-13","link":{"text":"https://clinicaltrials.gov/study/NCT05913947","untrusted":true}},{"nct_id":"NCT07484204","title":{"text":"Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia","untrusted":true},"phase":["PHASE1"],"sponsor":{"text":"Anxo Pharmaceutical Co., Ltd.","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-09-16","start_date":"2026-09-14","link":{"text":"https://clinicaltrials.gov/study/NCT07484204","untrusted":true}},{"nct_id":"NCT04777357","title":{"text":"A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"AbbVie","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-07-27","start_date":"2021-04-28","link":{"text":"https://clinicaltrials.gov/study/NCT04777357","untrusted":true}},{"nct_id":"NCT07266545","title":{"text":"RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Mayo Clinic","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-06-22","start_date":"2026-02-17","link":{"text":"https://clinicaltrials.gov/study/NCT07266545","untrusted":true}},{"nct_id":"NCT07185815","title":{"text":"Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine","untrusted":true},"phase":["PHASE1","PHASE2"],"sponsor":{"text":"Mapi Pharma Ltd.","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-05-01","start_date":"2025-08-01","link":{"text":"https://clinicaltrials.gov/study/NCT07185815","untrusted":true}}],"fact_id":"38536fd8a82ede86a693428f"}]},"spending":{"reported_under":{"generic":{"text":"Cariprazine HCl","untrusted":true},"brand":{"text":"Vraylar","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":487495093.42,"claims":375543,"beneficiaries":56285,"average_spending_per_claim_usd":1298.1072565,"fact_id":"2ed8804a5c057e37d87b12b5"},{"year":2021,"gross_spending_usd":583108993.45,"claims":436709,"beneficiaries":63398,"average_spending_per_claim_usd":1335.2346607,"fact_id":"f5135da0547a9dc1e07f7d94"},{"year":2022,"gross_spending_usd":708765555.05,"claims":509082,"beneficiaries":73893,"average_spending_per_claim_usd":1392.2424188,"fact_id":"e8fa434b257b0629416a8d1d"},{"year":2023,"gross_spending_usd":935653082.16,"claims":633278,"beneficiaries":98229,"average_spending_per_claim_usd":1477.4760566,"fact_id":"142b970241414d1dec3585f6"},{"year":2024,"gross_spending_usd":1135973310,"claims":766962,"beneficiaries":117573,"average_spending_per_claim_usd":1481.133759,"fact_id":"85ee3fce522d063bd5820760"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"medicaid_state_utilization":{"year":2025,"states_with_data":1,"all_states_medicaid_reimbursed_usd":76975.27,"all_states_medicaid_paid_prescriptions":100,"top_states":[{"state":"KY","medicaid_paid_prescriptions":100,"medicaid_reimbursed_usd":76975.27,"total_reimbursed_usd":76975.27,"packages":1,"covers":"all_record_types","fact_id":"c368923f62f5b3d9d207f549"}],"unlabelled_state_code_xx":null,"built_from_facts":1,"facts_fee_for_service_only":0,"older_year_facts_not_used":238,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"21bf9b93faf5ce4cdc26af0e","field":"ndc.listing","entity":"ndc:61874011517"},{"fact_id":"b61490ca429eba8f5af7123d","field":"ndc.listing","entity":"ndc:61874011520"},{"fact_id":"a85e356f0d07a8bd6954cc20","field":"ndc.listing","entity":"ndc:61874011530"},{"fact_id":"f1f46a95e84106b29c2cec11","field":"drug.generic_entry_earliest","entity":"application:NDA204370"},{"fact_id":"2f21c07ca466476f169b6acf","field":"drug.patent","entity":"application:NDA204370"},{"fact_id":"43b29f54eff0a5bdbf5ca9d9","field":"drug.exclusivity","entity":"application:NDA204370"},{"fact_id":"edd08c5b096812a808f08f48","field":"drug.label_event","entity":"application:NDA204370"},{"fact_id":"2b96c5ee7179871443e0eaa1","field":"drug.label_event","entity":"application:NDA204370"},{"fact_id":"744931a8ea68c9e13af34abf","field":"drug.label_event","entity":"application:NDA204370"},{"fact_id":"2f33dbbbdf8759849cc154b5","field":"drug.label_event","entity":"application:NDA204370"},{"fact_id":"af5a4bda7dd5af2d64b318fe","field":"drug.label_event","entity":"application:NDA204370"},{"fact_id":"ea37f2e34611ab7f4ae80d0d","field":"drug.te_code","entity":"application:NDA204370"},{"fact_id":"04a05085e424a4d7f199e1cf","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"c78712774f56ccf06c5120a0","field":"drug.te_code","entity":"application:NDA204370"},{"fact_id":"a154e428e205306c12ce4de1","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"c56cf4b4dc6613acbe3fab5c","field":"drug.te_code","entity":"application:NDA204370"},{"fact_id":"58e528061d190dc96e2469ab","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"a450ae5d0f7e24469c7d099e","field":"drug.te_code","entity":"application:NDA204370"},{"fact_id":"75ab9c50ead6a5d5dca06bbb","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"a1178f6b0452f9d1ff34fb9c","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"3817440447f6978033807145","field":"drug.marketing_status","entity":"application:NDA204370"},{"fact_id":"38536fd8a82ede86a693428f","field":"drug.trial_access","entity":"drug:cariprazine"},{"fact_id":"2ed8804a5c057e37d87b12b5","field":"drug.partd_spending","entity":"drug:cariprazine-hcl|vraylar"},{"fact_id":"f5135da0547a9dc1e07f7d94","field":"drug.partd_spending","entity":"drug:cariprazine-hcl|vraylar"},{"fact_id":"e8fa434b257b0629416a8d1d","field":"drug.partd_spending","entity":"drug:cariprazine-hcl|vraylar"},{"fact_id":"142b970241414d1dec3585f6","field":"drug.partd_spending","entity":"drug:cariprazine-hcl|vraylar"},{"fact_id":"85ee3fce522d063bd5820760","field":"drug.partd_spending","entity":"drug:cariprazine-hcl|vraylar"},{"fact_id":"c368923f62f5b3d9d207f549","field":"ndc.medicaid_state_utilization","entity":"ndc_state:61874013020:KY"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["AMBER","GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price.ratio","reason":"no package has both a brand-class NADAC price and a negotiated price in force"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"orphan_designation","reason":"no FDA orphan designation for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}